Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility, Accuracy, and Effect of Polyvalent Point-of-care Xpert MTB/RIF Ultra and Xpert HIV-1 Viral Load Testing in HIV-positive Patients Initiating ART: a Randomised Controlled Trial

NCT03187964 is registered in ClinicalTrials.gov with University of Stellenbosch as lead sponsor.

NCT NCT03187964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03187964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility, Accuracy, and Effect of Polyvalent Point-of-care Xpert MTB/RIF Ultra and Xpert HIV-1 Viral Load Testing in HIV-positive Patients Initiating ART: a Randomised Controlled Trial
Lead sponsor
University of Stellenbosch
Phase
Not applicable
Overall status
Completed
Start date
February 5, 2018
Completion date
April 4, 2022
Enrollment
1,053 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiretroviral therapy, highly active, hiv/aids, tb - tuberculosis